McDermott advised Dynacure on its merger. Dynacure, a company that aims to develop and commercialize new therapies to improve the lives of patients with rare diseases...
Dynacure’s Merger with Flamingo Therapeutics
Dynacure’s Agreement With Nippon Shinyaku
McDermott Will & Emery advised Dynacure on the deal. Dynacure, a clinical-stage company focused on developing and commercializing innovative therapies to transform the lives of patients...